lexi
IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 4635 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Pharmacological basis for application of scutellarin in Alzheimer's disease: Antioxidation and antiapoptosis
Xinyu Hu,Shanshan Teng,Jiawei He,Xiaoqi Sun,Mingzhao Du,Ling Kou,Xiaofeng Wang
Molecular Medicine Reports.2018;()
[DOI]
2Pharmacological basis for application of scutellarin in Alzheimer's disease: Antioxidation and antiapoptosis
Cally Xiao,Scott C. Neu,Arthur W. Toga
Molecular Medicine Reports.2022;()395
[DOI]
3Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer’s disease rats
Weiwei Hu,Zehua Feng,Jun Xu,Zhi Jiang,Meijiang Feng
Brain Research.2019;1710()61
[DOI]
4TAU IMMUNOTHERAPY FOR ALZHEIMER’S (Review Article)
ABIVARMA CHANDRAKUMARAN,ASHWIN ACHUTHAPRASAD,PAK DANIEL,JOEL JACOB
EXPERIMENTAL & CLINICAL MEDICINE GEORGIA.2022;1710()61
[DOI]
5Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment
Maria Rosito,Claudia Testi,Giacomo Parisi,Barbara Cortese,Paola Baiocco,Silvia Di Angelantonio
Antioxidants.2020;9(8)700
[DOI]
6The calcium-free form of atorvastatin inhibits amyloid-ß(1–42) aggregation in vitro
Hadi Nedaei,Nasrollah Rezaei-Ghaleh,Karin Giller,Stefan Becker,Leila Karami,Ali Akbar Moosavi-Movahedi,Christian Griesinger,Ali Akbar Saboury
Journal of Biological Chemistry.2022;298(3)101662
[DOI]
7Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches
Derek Kellar,Suzanne Craft
The Lancet Neurology.2020;19(9)758
[DOI]
8BDMC protects AD in vitro via AMPK and SIRT1
Chenlin Xu,Zijian Xiao,Heng Wu,Guijuan Zhou,Duanqun He,Yunqian Chang,Yihui Li,Gang Wang,Ming Xie
Translational Neuroscience.2020;11(1)319
[DOI]
9Alzheimer’s Disease: Perspective on Therapeutic Options and Recent Hallmarks in Clinical Research
Aubine Molly Beera,Sarvan Manikiran Seethamraju,Lakshmi Prasanthi Nori
International Journal Of Pharmaceutical Research And Allied Sciences.2021;10(4)110
[DOI]
10??????????? ?????????????? ??????? ???????????, "?????? ??????????????? ????"
?.?. ????,?. ?. ???????,?. ?. ????????,?. ?. ???????
?????? ??????????????? ????.2018;10(4)45
[DOI]
11Graphene oxide enhances ß-amyloid clearance by inducing autophagy of microglia and neurons
Xiaolin Li,Kai Li,Fangxuan Chu,Jie Huang,Zhuo Yang
Chemico-Biological Interactions.2020;325(4)109126
[DOI]
12Identification of amyloid antibodies for Alzheimer disease – immunotherapy
Etimad A. Huwait,Ibtisam M. Baghallab,Charles G. Glabe,Khalid O. Abulnaja,Taha A. Kumosani,Said S. Moselhy
Archives of Physiology and Biochemistry.2020;325(4)1
[DOI]
13Stem cell therapy for Alzheimer's disease
Xin-Yu Liu,Lin-Po Yang,Lan Zhao
World Journal of Stem Cells.2020;12(8)787
[DOI]
14Therapie der Alzheimer-Demenz — was kommt?
Michael Hosch,Lioba Klaas,Annika Welchar,Marie Louise Aicher,Benedikt Obermaier,Vinona Wicht,Richard Dodel
InFo Neurologie & Psychiatrie.2017;19(11)36
[DOI]
15Promising tacrine/huperzine A-based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget
Shinghung Mak,Wenming Li,Hongjun Fu,Jialie Luo,Wei Cui,Shengquan Hu,Yuanping Pang,Paul R. Carlier,Karl Wahkeung Tsim,Rongbiao Pi,Yifan Han
Journal of Neurochemistry.2021;158(6)1381
[DOI]
16Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects
Lei Sheng,Wei Cao,Pingping Lin,Weili Chen,Hongrong Xu,Chunjiu Zhong,Fei Yuan,Hanjing Chen,Hui Li,Chao Liu,Mengjie Yang,Xuening Li
Drug Design, Development and Therapy.2021;Volume 15(6)1101
[DOI]
17Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects
R. Navanietha Krishnaraj,Dipayan Samanta,Rajesh K. Sani
Drug Design, Development and Therapy.2018;132(6)613
[DOI]
18Effects of Single Amino Acid Substitutions on Aggregation and Cytotoxicity Properties of Amyloid ß Peptide
Ana Esther Estrada-Rodríguez,Donato Valdez-Pérez,Jaime Ruiz-García,Alejandro Treviño-Garza,Ana Miriam Gómez-Martínez,Herminia Guadalupe Martínez-Rodríguez,Ana María Rivas-Estilla,Román Vidaltamayo,Viviana Zomosa-Signoret
International Journal of Peptide Research and Therapeutics.2019;25(2)493
[DOI]
19Current status and future prospects of stem cell therapy in Alzheimer’s disease
Fu-Qiang Zhang,Jin-Lan Jiang,Jing-Tian Zhang,Han Niu,Xue-Qi Fu,Lin-Lin Zeng
Neural Regeneration Research.2020;15(2)242
[DOI]
20Genetic variation and function of the HIV-1 Tat protein
Cassandra Spector,Anthony R. Mele,Brian Wigdahl,Michael R. Nonnemacher
Medical Microbiology and Immunology.2019;208(2)131
[DOI]
21Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis
B. Teter,T. Morihara,G.P. Lim,T. Chu,M.R. Jones,X. Zuo,R.M. Paul,S.A. Frautschy,G.M. Cole
Neurobiology of Disease.2019;127(2)432
[DOI]
22Moderate- to high-intensity exercise does not modify cortical ß-amyloid in Alzheimer's disease
Kristian S. Frederiksen,Karine Madsen,Birgitte B. Andersen,Nina Beyer,Ellen Garde,Peter Høgh,Gunhild Waldemar,Steen G. Hasselbalch,Ian Law
Alzheimer's & Dementia: Translational Research & Clinical Interventions.2019;5(1)208
[DOI]
23Alzheimer’s Disease and Retinal Degeneration: A Glimpse at Essential Trace Metals in Ocular Fluids and Tissues
Alessandra Micera,Luca Bruno,Andrea Cacciamani,Mauro Rongioletti,Rosanna Squitti
Current Alzheimer Research.2020;16(12)1073
[DOI]
24Multiple mechanisms of dimethyl fumarate in amyloid ß-induced neurotoxicity in human neuronal cells
Michela Campolo,Giovanna Casili,Marika Lanza,Alessia Filippone,Irene Paterniti,Salvatore Cuzzocrea,Emanuela Esposito
Journal of Cellular and Molecular Medicine.2017;16(12)1073
[DOI]
25Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases
Sarah A. Scuderi,Alessio Ardizzone,Irene Paterniti,Emanuela Esposito,Michela Campolo
Antioxidants.2020;9(7)630
[DOI]
26A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer’s Disease
Sanchari Mukhopadhyay,Debanjan Banerjee,Jagannatha Rao Kosagisharaf
Journal of Alzheimer's Disease.2021;83(4)1537
[DOI]
27Epitomic Characterization of the Specificity of the Anti-Amyloid Aß Monoclonal Antibodies 6E10 and 4G8
Ibtisam Baghallab,Jorge Mauricio Reyes-Ruiz,Khalid Abulnaja,Etimad Huwait,Charles Glabe,Elizabeth Head
Journal of Alzheimer's Disease.2018;66(3)1235
[DOI]
28Isorhynchophylline alleviates learning and memory impairments induced by aluminum chloride in mice
Hui-Qin Li,Siu-Po Ip,Guo-Qing Zheng,Yan-Fang Xian,Zhi-Xiu Lin
Chinese Medicine.2018;13(1)1235
[DOI]
29Advances and challenges in therapeutic monoclonal antibodies drug development
Mariana Lopes dos Santos,Wagner Quintilio,Tania Maria Manieri,Lilian Rumi Tsuruta,Ana Maria Moro
Brazilian Journal of Pharmaceutical Sciences.2018;54(spe)1235
[DOI]
30Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants
Julie Hoogmartens,Rita Cacace,Christine Van Broeckhoven
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.2021;13(1)1235
[DOI]
31Anti-Oxidative Stress Activity Is Essential for Amanita caesarea Mediated Neuroprotection on Glutamate-Induced Apoptotic HT22 Cells and an Alzheimer’s Disease Mouse Model
Zhiping Li,Xia Chen,Wenqian Lu,Shun Zhang,Xin Guan,Zeyu Li,Di Wang
International Journal of Molecular Sciences.2017;18(8)1623
[DOI]
32Anti-amyloid Therapy of Alzheimer’s Disease: Current State and Prospects
S. A. Kozin,E. P. Barykin,V. A. Mitkevich,A. A. Makarov
Biochemistry (Moscow).2018;83(9)1057
[DOI]
33A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley?
Thomas G. Beach
Neurology and Therapy.2017;6(S1)5
[DOI]
34Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disease by up-regulating SIRT1
Yan Xu,Rong Hu,Duanqun He,Guijuan Zhou,Heng Wu,Chenlin Xu,Bing He,Lin Wu,Yilin Wang,Yunqian Chang,Rundong Ma,Ming Xie,Zijian Xiao
Brain and Behavior.2020;10(7)5
[DOI]
35Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer’s Disease
Ankit Ganeshpurkar,Rayala Swetha,Devendra Kumar,Gore P. Gangaram,Ravi Singh,Gopichand Gutti,Srabanti Jana,Dileep Kumar,Ashok Kumar,Sushil K. Singh
Current Topics in Medicinal Chemistry.2019;19(7)501
[DOI]
36Genetic dependency of Alzheimer’s disease-associated genes across cells and tissue types
Suraj K. Jaladanki,Abdulkadir Elmas,Gabriel Santos Malave,Kuan-lin Huang
Scientific Reports.2021;11(1)501
[DOI]
37Genetic dependency of Alzheimer’s disease-associated genes across cells and tissue types
A. J. Larner
Scientific Reports.2019;11(1)163
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow